Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1221-1240 of 3,190 trials

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

NCT05990920

The goal of this clinical trial is to test SNK02 in participants with pathologically confirmed cancer that is refractory to conventional therapy. The main questions it aims to answer are: * Is SNK02 safety and tolerable when administered weekly as an intravenous infusion * What is the maximum dose that is tolerated of SNK02 Participants will be administered SNK02 weekly for 8 weeks and undergo medical evaluation to provide initial clinical safety data for the treatment of cancer with allogeneic NK cells as a monotherapy treatment.

Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more

NKGen Biotech, Inc.6 participantsStarted Aug 2023

Los Angeles, California, United States • Santa Monica, California, United States

COMPLETED< 1 mile

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

NCT02380274

The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.

Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer

Astellas Pharma Global Development, Inc.1,030 participantsStarted Mar 2015

Homewood, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +145 more locations

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Rheumatoid Arthritis Trials in Other Cities

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Dashboard Activated Services and Tele-Health for Heart Failure

18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

North American Prodromal Synucleinopathy Consortium

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis.

A Study to Assess the Effect of My Happy Flo on Alleviating Period Symptoms and Heavy Flows.

Entyvio (Vedolizumab) Long Term Safety Study

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Preemie Hypothermia for Neonatal Encephalopathy

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Other Conditions in Los Angeles